The effects of chronic treatment with the 5-hydroxytryptamine uptake blocker zimelidine on central 5-hydroxytryptamine mechanisms. Evidence for the induction of a low affinity binding site for 5-hydroxytryptamine.

Source:http://linkedlifedata.com/resource/pubmed/id/530482

Download in:

View as

General Info

PMID
530482